NIH-funded research NIH-funded research

Promoting spinal cord repair by targeting FL2 protein

Official title: Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2.

Funded at Microcures, INC. · NIH-11330231 · Data updated 2026-11-12

A patient-facing program is testing a tiny therapy that targets a specific brain/spinal cord protein to help people recover movement after a spinal cord injury.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMicrocures, INC.
NIH-funded
Lab location1 site (Santa Cruz, United States)
Project startMay 15, 2025
Project endApril 30, 2027
Funding year2026
Award (this year)$235,898
NIH project number5R41NS137941-02
Project IDNIH-11330231 on NIH RePORTER

Who could benefit from this research

Could help

Adults with acute spinal cord injury who could be eligible for future translational studies.

Less likely to help

People with injuries outside the studied window or with conditions not responsive to FL2 targeting may not benefit.

What this research studies

This project uses a nanoparticle system to deliver a small interfering RNA against FL2, a protein that normally slows nerve growth. In rat injury models, removing FL2 locally has improved movement after spinal cord damage, and the team will test similar approach in larger animal groups. The study will apply the treatment onto the spinal dura or via intrathecal injection and measure whether hindlimb function, bladder control, and other recovery improve. If proof of feasibility is shown, the work could inform future studies aiming to translate this therapy to human patients with spinal cord injury.

Why it matters

Potential benefit: If successful, the approach could enhance nerve regrowth and functional recovery after spinal cord injury, potentially restoring movement and autonomic function.

How similar studies have gone: Preclinical studies in rats showed improved locomotor recovery after FL2 depletion.

Where this research is happening

  • Microcures, INC.
    Santa Cruz, United States
    Active

Researchers

  • Principal investigator: Baker, Lisa Ann — Microcures, INC.
  • Study coordinator: Baker, Lisa Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.